Global Non-Invasive Prenatal Testing Market Forecast to 2027
The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.
Despite NIPT being accessible in growing amounts of regions, there is a major commercial push expected to assist consumer expansion in the projected years. NIPT was confirmed through similarities with standard prenatal aneuploidy screening and found to be a beneficial screening procedure with keen sensitivity and specificity. Increasing popularity among pregnant women as an alternative to amniocentesis and awareness of prenatal genetic problems drives non-invasive prenatal testing.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
The competitive landscape of the report has been formulated by considering all the vital parameters such as company profiling, market share, recent developments and advancements, gross margins, product portfolio, revenue generation, financial standing, market position, and expansion plans. The report also discusses in detail the recent mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, agreements, corporate and government deals, and partnerships, among others. The report also sheds light on the recent technological developments and product advancements in the Non-Invasive Prenatal Testing market.
Furthermore, the report provides details about the new players entering the market, entry-level barriers and offers strategic recommendations to overcome those barriers to gain a substantial industry presence.
Key Players operating in the industry are:
Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.
The Global Non-Invasive Prenatal Testing Market is further analyzed across the key geographical locations where the market has expanded to a significant size. The key region analyzed are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report offers a country-wise analysis to provide a comprehensive analysis of the Non-Invasive Prenatal Testing market in terms of production and consumption patterns, supply and demand ratio, import/export, revenue contribution, trends, and presence of prominent players in each region.
Regional Analysis Covers:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The all-inclusive report on the Global Non-Invasive Prenatal Testing Market added by Reports and Data demonstrates that the global Non-Invasive Prenatal Testing market is presumed to grow at a steady CAGR throughout the forecast timeline. The report analyzed the key market drivers, restraints, growth opportunities, investment opportunities, threats, and limitations of the Non-Invasive Prenatal Testing market. The report also offers accurate forecast estimation at a global and regional level to impart a better understanding of the scope of the market.
Radical Features of the Non-Invasive Prenatal Testing Market Report:
- The report encompasses Non-Invasive Prenatal Testing market overview along with market share, demand and supply ratio, production and consumption patterns, supply chain analysis, and other ley elements
- An in-depth analysis of the different approaches and procedures undertaken by the key players to conduct business efficiently
- Offers insights into production and manufacturing value, products and services offered in the market, and fruitful information about investment strategies
- Supply chain analysis along with technological advancements offered in the report
- The report covers extensive analysis of the trends, drivers, restraints, limitations, threats, and growth opportunities in the Non-Invasive Prenatal Testing industry
Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.
About Emergen Research
At Emergen Research, we believe in advancing with technology. We are a growing Marketresearch and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.